New hope for leukemia patients: experimental combo targets tough cases
Disease control
Recruiting now
This study is testing whether adding a new drug called emavusertib to an existing cancer medication (zanubrutinib) can better control chronic lymphocytic leukemia and similar blood cancers. It will enroll 108 adults who are already taking zanubrutinib but need additional treatmen…
Phase: PHASE2 • Sponsor: Curis, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC